The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 123 results:
Author [ Title(Desc)] Type Year
Filters: Author is Tsapas, Apostolos  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
I
Liakos, A., Tsapas A., & Bekiari E. (2020).  In type 2 diabetes, SGLT2 inhibitors were linked to diabetic ketoacidosis vs. DPP-4 inhibitors.. Ann Intern Med. 173(12), JC70.
Bekiari, E., Karagiannis T., & Tsapas A. (2018).  In type 2 diabetes, weekly semaglutide reduced HbA 1c and increased weight loss more than weekly exenatide ER. Annals of Internal Medicine. 168(8), JC46.
Bekiari, E., Karagiannis T., & Tsapas A. (2018).  In type 2 diabetes, weekly semaglutide reduced HbA1c and increased weight loss more than weekly exenatide ER.. Ann Intern Med. 168(8), JC46.
Prutsky, G., Domecq J. Pablo, & Tsapas A. (2012).  Insulin secretagogues were associated with increased mortality compared with metformin in type 2 diabetes.. Ann Intern Med. 156(2), JC1-7.
Avgerinos, K. I., Chatzisotiriou A., Haidich A-B., Tsapas A., & Lioutas V-A. (2019).  Intravenous Magnesium Sulfate in Acute Stroke.. Stroke. 50(4), 931-938.
Sarigianni, M., Tsapas A., Mikhailidis D. P., Kaloyianni M., Koliakos G., & Paletas K. (2010).  Involvement of signaling molecules on na/h exchanger-1 activity in human monocytes.. Open Cardiovasc Med J. 4, 181-8.
K
Karagiannis, T., Tsapas A., & Bekiari E. (2021).  KDIGO made 12 recommendations for managing diabetes with CKD.. Ann Intern Med. 174(3), JC26.
M
Inzucchi, S. E., Bergenstal R. M., Buse J. B., Diamant M., Ferrannini E., Nauck M., et al. (2015).  Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.. Diabetologia. 58(3), 429-42.
Davies, M. J., Aroda V. R., Collins B. S., Gabbay R. A., Green J., Maruthur N. M., et al. (2022).  Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).. Diabetologia.
Inzucchi, S. E., Bergenstal R. M., Buse J. B., Diamant M., Ferrannini E., Nauck M., et al. (2015).  Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.. Diabetes Care. 38(1), 140-9.
Davies, M. J., Aroda V. R., Collins B. S., Gabbay R. A., Green J., Maruthur N. M., et al. (2022).  Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).. Diabetes Care.
Liakos, A., Karagiannis T., Avgerinos I., Malandris K., Tsapas A., & Bekiari E. (2023).  Management of type 2 diabetes in the new era.. Hormones (Athens). 22(4), 677-684.
Karagiannis, T., Avgerinos I., Liakos A., Del Prato S., Matthews D. R., Tsapas A., et al. (2022).  Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis.. Diabetologia. 65(8), 1251-1261.
Spanos, C. P., Tsapas A., Abatzis-Papadopoulos M., Theodorakou E., & Marakis G. N. (2014).  Medical student recognition of benign anorectal conditions: the effect of attending the outpatient colorectal clinic.. BMC Surg. 14, 95.
Bekiari, E., Karagiannis T., Haidich A-B., & Tsapas A. (2017).  Meta-analysis of artificial pancreas trials: methodological considerations. The Lancet Diabetes & Endocrinology. 5(9), 685.
Bekiari, E., Karagiannis T., Haidich A-B., & Tsapas A. (2017).  Meta-analysis of artificial pancreas trials: methodological considerations.. Lancet Diabetes Endocrinol. 5(9), 685.
Karagiannis, T., Tsapas A., Bekiari E., Toulis K. A., & Nauck M. A. (2024).  A Methodological Framework for Meta-analysis and Clinical Interpretation of Subgroup Data: The Case of Major Adverse Cardiovascular Events With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes.. Diabetes Care. 47(2), 184-192.
Hill, N. R., Tsapas A., Hindmarsh P., & Matthews D. R. (2013).  Methodology for quantifying fasting glucose homeostasis in type 2 diabetes: observed variability and lability.. J Diabetes Sci Technol. 7(3), 640-5.
Kostidou, E., Trachana V., Topouridou K., Paletas K., Tsapas A., Kaloyianni M., et al. (2009).  Monocyte attachment to laminin in diabetes mellitus: The role of ATP.. Cell Adh Migr. 3(2), 155-9.
N
Sarigianni, M., Tsapas A., Mikhailidis D. P., Kaloyianni M., Koliakos G., Fliegel L., et al. (2010).  Na+ H+ exchanger-1: a link with atherogenesis?. Expert Opin Investig Drugs. 19(12), 1545-56.
Nikolaidou, B., Anyfanti P., Gavriilaki E., Lazaridis A., Triantafyllou A., Zarifis H., et al. (2022).  Non-dipping pattern in early-stage diabetes: association with glycemic profile and hemodynamic parameters.. J Hum Hypertens. 36(9), 805-810.
Sarigianni, M., Dimitrakopoulos K., & Tsapas A. (2014).  Non-dipping status in arterial hypertension: an overview.. Curr Vasc Pharmacol. 12(3), 527-36.
O
Rizos, E. C., Markozannes G., Tsapas A., Mantzoros C. S., & Ntzani E. E. (2021).  Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis.. Heart. 107(2), 150-158.
Stoimenis, D., Karagiannis T., Katsoula A., Athanasiadou E., Kazakos K., Bekiari E., et al. (2017).  Once-weekly dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a systematic review and meta-analysis. Expert Opinion on Pharmacotherapy. 18555857646565(9111111), 843 - 851.
Stoimenis, D., Karagiannis T., Katsoula A., Athanasiadou E., Kazakos K., Bekiari E., et al. (2017).  Once-weekly dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a systematic review and meta-analysis.. Expert Opin Pharmacother. 18(9), 843-851.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.